The global veterinary nutraceuticals market was valued at USD 4.55 billion in 2025. This market is expected to reach USD 10.17 billion by 2036, growing from USD 4.89 billion in 2026, at a CAGR of 7.6% from 2026 to 2036.

The veterinary nutraceuticals market has evolved from a niche segment of the overall animal healthcare into a critical component of modern veterinary medicine and animal nutrition. The animal health management relied primarily on pharmaceuticals, vaccines, and therapeutic interventions to address diseases after clinical onset. However, growing awareness of preventive healthcare, increasing concerns regarding antimicrobial resistance, and the rapid humanization of companion animals have transformed how animal health is managed. Today, nutraceuticals are increasingly incorporated into preventive care programs, chronic disease management strategies, and livestock nutrition systems to support long-term health, productivity, and animal welfare.

The growing importance of veterinary nutraceuticals is closely linked to the expansion of the global pet population and rising spending on animal healthcare. According to the American Pet Products Association (APPA), U.S. pet industry expenditures reached around USD 152 billion in 2024, compared with less than USD 100 billion a decade ago, highlighting the increasing willingness of pet owners to invest in premium healthcare and wellness products. Furthermore, the European Pet Food Industry Federation (FEDIAF) estimates that Europe is home to more than 166 million dogs and cats, while global pet ownership continues to expand across emerging markets. As pets increasingly occupy the role of family members, demand for joint health supplements, probiotics, omega-3 fatty acids, cognitive support products, and condition-specific nutritional solutions continues to rise.

The livestock sector is also becoming a major driver of nutraceutical adoption. According to the Food and Agriculture Organization (FAO), global meat production exceeded 360 million tonnes annually, while demand for animal protein is expected to continue increasing over the coming decades. Simultaneously, regulatory authorities worldwide are tightening controls on the routine use of antibiotics in food-producing animals. The ban of the European Union on antibiotic growth promoters and similar antimicrobial stewardship initiatives across North America and Asia have accelerated the adoption of probiotics, prebiotics, phytogenics, yeast derivatives, organic acids, and immune-support nutraceuticals as alternative tools for maintaining animal health and productivity.

Growing research into the animal microbiome has demonstrated the critical role of gut health in immunity, nutrient absorption, growth performance, and disease resistance. As a result, probiotic and digestive health products have emerged as some of the fastest-growing veterinary nutraceutical categories. Similarly, osteoarthritis remains one of the most common chronic conditions in aging companion animals. Studies published by veterinary orthopedic associations indicate that approximately 20% of adult dogs and up to 80% of senior dogs show evidence of osteoarthritis, driving strong demand for glucosamine, chondroitin, collagen, and omega-3-based joint health supplements.

The market is also benefiting from increasing investment by leading animal health and nutrition companies. Major players are expanding their portfolios of functional supplements, condition-specific nutraceuticals, and precision nutrition products designed for companion animals, poultry, swine, ruminants, and aquaculture species. Advances in formulation technologies, palatability enhancement, microencapsulation, and bioavailability optimization are improving product efficacy and consumer acceptance. As veterinary care increasingly shifts toward prevention, wellness, and long-term health management, nutraceuticals are expected to become an increasingly important component of animal healthcare systems worldwide.

Key Market Highlights

• North America accounts for around 35–40% of the global veterinary nutraceuticals market in 2026, driven by high pet ownership and veterinary spending.
• U.S. pet industry spending reached around USD 160 billion in 2025, driving demand for premium pet wellness products.
• Asia-Pacific is projected to be the fastest-growing regional market through 2036, driven by pet humanization and rising disposable incomes.
• China, India, and Japan are key growth markets due to expanding pet populations and premium pet care adoption.
• Companion Animals are the largest animal type segment, accounting for the majority of veterinary nutraceutical demand in 2026
• Dogs hold the largest share within the companion animal segment due to higher healthcare spending and supplement usage.
• Europe is home to more than 166 million dogs and cats, supporting strong demand for companion animal nutraceuticals.
• Joint Health Supplements represent the largest product category by revenue.
• Approximately 20% of adult dogs and up to 80% of senior dogs are affected by osteoarthritis.
• Glucosamine, chondroitin, MSM, and omega-3 products remain the most widely used joint health ingredients.
• Digestive Health Supplements are among the fastest-growing product segments globally.
• Probiotics and prebiotics are increasingly used to support gut health, immunity, and feed efficiency.
• Preventive Care & General Wellness account for the largest application segment in 2026
• Preventive healthcare is becoming a major focus among pet owners and veterinarians.
• Restrictions on antibiotic use are accelerating nutraceutical adoption in livestock production.
• Poultry and ruminants represent key livestock markets for probiotics and immune-support products.
• Microbiome-based nutraceuticals are emerging as a major innovation area in animal health.
• Veterinary nutraceuticals are increasingly used alongside pharmaceuticals for chronic disease management.
• Leading companies are investing in condition-specific, species-specific, and science-backed formulations.
• Companion animal products generate higher margins than livestock nutraceutical products.

Key Trends Driving the Veterinary Nutraceuticals Market

Transition toward Synergistic, Multi-Ingredient Functional Formulations

A key trend in the veterinary nutraceuticals market is the shift from single-ingredient supplements toward scientifically formulated, multi-ingredient products designed to address specific health conditions. Historically, veterinary nutraceuticals focused on individual ingredients such as glucosamine, fish oil, or probiotics. Today, manufacturers are increasingly combining multiple bioactive compounds to target several physiological pathways simultaneously and deliver broader health benefits.

The trend is being driven by the growing burden of chronic health conditions in companion animals. Osteoarthritis affects around 20% of adult dogs and up to 80% of senior dogs, making mobility support one of the largest nutraceutical application areas. As a result, modern joint-health products increasingly combine glucosamine, chondroitin, MSM, collagen peptides, omega-3 fatty acids, hyaluronic acid, and antioxidants rather than relying on a single active ingredient.

Digestive health formulations are evolving in a similar manner. Scientific advances in animal microbiome research have highlighted the close relationship between gut health, immunity, nutrient absorption, and overall animal performance. Consequently, manufacturers are increasingly developing formulations that combine probiotics, prebiotics, postbiotics, digestive enzymes, yeast derivatives, and immune-support ingredients in a single product. Veterinary research also shows growing use of omega-3 fatty acids, probiotics, and plant-derived nutraceuticals for managing gastrointestinal, immune, skin, and cognitive health conditions.

Market activity further supports this trend. Joint-health supplements remain the largest application category within the pet supplement industry, accounting for nearly 30% of market demand in several industry assessments, while glucosamine-chondroitin combinations continue to rank among the most widely utilized veterinary nutraceutical products. Probiotic and digestive-health formulations are also among the fastest-growing categories due to increasing veterinary recommendations and consumer focus on preventive care.

Leading companies including Nutramax Laboratories, Virbac, VetPlus, Zoetis, and Elanco are increasingly investing in condition-specific formulations that combine multiple active ingredients within a single dosage form. These advanced formulations improve convenience, compliance, and product differentiation while aligning with the growing demand for evidence-based, preventive animal healthcare solutions. As veterinary care increasingly focuses on long-term wellness and chronic disease management, multi-ingredient nutraceuticals are expected to capture a growing share of market revenue throughout the forecast period.

Growing Adoption of Direct-to-Consumer (DTC) Digital Subscription Models

Another major trend reshaping the veterinary nutraceuticals market is the rapid growth of direct-to-consumer (DTC) and digital purchasing channels. Historically, veterinary supplements were primarily sold through veterinary clinics, specialty pet stores, and animal health distributors. Today, pet owners increasingly purchase nutraceuticals through online platforms, brand-owned websites, subscription services, and e-commerce marketplaces, reflecting broader shifts in consumer purchasing behavior.

The trend is supported by the rapid expansion of online pet product sales. According to the American Pet Products Association (APPA), online channels now account for a significant share of pet product purchases in the United States, with digital adoption accelerating following the COVID-19 pandemic. In addition, data from the Packaged Facts indicates that more than 50% of pet owners purchase pet products online, highlighting the growing importance of digital sales channels.

Subscription-based purchasing models are gaining traction in the nutraceutical category because many products are used daily for long-term conditions. For example, dogs diagnosed with osteoarthritis often require continuous supplementation for months or years, while probiotics, skin & coat supplements, and cognitive support products are increasingly incorporated into routine wellness programs. This recurring usage pattern makes veterinary nutraceuticals well suited for automated replenishment and subscription services.

Several leading brands, including Nutramax, Zesty Paws, Pet Honesty, and numerous veterinary-recommended supplement providers, have expanded direct-to-consumer capabilities through online stores, personalized wellness recommendations, auto-ship programs, and digital customer engagement platforms. At the same time, major e-commerce platforms continue to expand pet health and wellness product offerings, improving product accessibility for consumers.

The shift toward DTC channels provides several advantages, including greater customer convenience, recurring revenue opportunities, stronger brand loyalty, and access to consumer purchasing data. As online pet healthcare spending continues to grow and digital engagement becomes increasingly important, e-commerce and subscription-based distribution models are expected to play a larger role in veterinary nutraceutical sales throughout the forecast period.

Segment Analysis

By Animal Type

Companion Animals

Companion animals hold the largest share of the overall veterinary nutraceuticals market, with dogs accounting for the majority of segment revenue. This dominance is driven by rising pet ownership, increasing pet healthcare expenditure, longer pet lifespans, and growing demand for preventive wellness products.

According to the European Pet Food Industry Federation (FEDIAF), Europe is home to approximately 106 million dogs and 60 million cats, while the American Veterinary Medical Association (AVMA) estimates that nearly 46.5 million U.S. households own dogs. In addition, dogs typically generate significantly higher veterinary spending than most other companion animals due to greater utilization of healthcare, wellness, and nutritional products.

Age-related health conditions are a major driver of supplement demand. Veterinary studies indicate that around 20% of adult dogs and up to 80% of senior dogs are affected by osteoarthritis, supporting strong demand for glucosamine, chondroitin, collagen, and omega-3 supplements. Similarly, gastrointestinal disorders, obesity, cognitive decline, and skin conditions are increasing the demand for probiotics, digestive enzymes, antioxidants, and cognitive-support nutraceuticals. As pet owners increasingly prioritize quality of life and healthy aging, companion animals are expected to remain the largest revenue-generating segment throughout the forecast period.

Livestock Animals

Livestock animals are the fastest-growing segment of the veterinary nutraceuticals market, driven by increasing demand for antibiotic alternatives, improved animal productivity, and sustainable livestock production practices. Poultry and swine account for a significant share of demand due to the scale and intensity of commercial production systems.

According to the Food and Agriculture Organization (FAO), global poultry meat production exceeds 140 million tonnes annually, making poultry the world's largest animal protein category. At the same time, global feed production surpassed 1.3 billion tonnes, highlighting the enormous scale of animal nutrition markets. Even small improvements in feed efficiency, disease resistance, or animal performance can generate substantial economic benefits for producers.

The segment is benefiting from increasing adoption of probiotics, prebiotics, phytogenics, yeast derivatives, organic acids, and immune-support products as producers seek to improve gut health and reduce reliance on antibiotics. Research has shown that feed additives supporting microbiome health can improve feed conversion ratios, growth performance, and disease resilience in poultry, swine, ruminants, and aquaculture species. As global demand for meat, milk, eggs, and seafood continues to increase, livestock producers are expected to remain major adopters of veterinary nutraceutical products.

By Product Type

Joint Health Supplements

Joint Health Supplements are the largest product category within the veterinary nutraceuticals market. The large share of this segment is primarily driven by the high prevalence of musculoskeletal disorders in companion animals, particularly aging dogs, large breeds, and performance horses. As pet lifespans continue to increase, mobility-related conditions are becoming a major focus of preventive veterinary care.

According to veterinary studies, approximately 20% of adult dogs and up to 80% of dogs over the age of 8 years show evidence of osteoarthritis. Furthermore, hip dysplasia affects nearly 15–20% of large-breed dogs in several high-risk breeds. These conditions often require long-term management, supporting sustained demand for joint health products.

Glucosamine, chondroitin sulfate, MSM, collagen peptides, hyaluronic acid, and omega-3 fatty acids remain among the most widely used ingredients in veterinary joint supplements. Products such as Nutramax's Cosequin and Dasuquin have become widely recognized among veterinarians and pet owners, reflecting the strong clinical and commercial adoption of joint-support nutraceuticals. The combination of high disease prevalence, lifelong supplementation needs, and strong veterinary recommendation rates continues to make joint health the largest revenue-generating product segment.

Digestive Health Supplements

Digestive Health Supplements are expected to register the fastest growth during the forecast period. The growth of this market is mainly attributed to the increasing scientific understanding of the animal microbiome and its role in digestion, immunity, nutrient utilization, and overall health.

The gastrointestinal disorders account for approximately 10–15% of veterinary consultations in companion animals, while digestive diseases remain among the most common causes of productivity losses in poultry and swine production. This has increased demand for probiotics, prebiotics, postbiotics, digestive enzymes, yeast derivatives, and gut-health formulations across both companion animal and livestock sectors.

Following restrictions on antibiotic growth promoters in many countries, producers have increasingly adopted microbiome-support products to maintain gut integrity and improve feed efficiency. Research has shown that probiotic supplementation can improve feed conversion performance and support disease resistance in poultry, swine, aquaculture, and ruminant production systems.

Innovation is also accelerating. Companies are investing heavily in strain-specific probiotics, microencapsulation technologies, and precision microbiome solutions designed to improve stability, survivability, and efficacy. As veterinarians and producers increasingly recognize the link between gut health and overall animal performance, digestive health supplements are expected to remain one of the fastest-growing product categories in the veterinary nutraceuticals market.

By Geography

North America Veterinary Nutraceuticals Market

North America is the largest regional market for veterinary nutraceuticals, accounting for approximately 35–40% of global revenue. The largest share of this region is primarily attributed to its highly developed veterinary healthcare infrastructure, strong penetration of pet insurance, advanced companion animal diagnostics, and widespread availability of premium animal health products.

The U.S. has one of the world's most mature veterinary industries. According to the American Veterinary Medical Association (AVMA), the country has more than 127,000 licensed veterinarians, supporting broad access to preventive healthcare services and veterinary-recommended nutraceutical products. In addition, the North American Pet Health Insurance Association (NAPHIA) reports that more than 7 million pets were insured in North America in 2024, reflecting increasing willingness among owners to invest in long-term health management and wellness programs.

North America is also a global center for veterinary innovation and product commercialization. Many of the leading nutraceutical companies, including Nutramax Laboratories, Zoetis, Elanco, and numerous specialty supplement brands, are headquartered in the region. The strong presence of veterinary specialists, research institutions, and animal health manufacturers accelerates product development, clinical validation, and market adoption.

The region additionally benefits from one of the world's most advanced pet retail and veterinary distribution networks. Veterinary nutraceutical products are widely available through veterinary hospitals, specialty pet retailers, online pharmacies, and subscription-based wellness platforms, improving accessibility and supporting recurring purchases. Combined with a mature animal healthcare ecosystem and strong innovation capabilities, these factors are expected to maintain North America's leadership position throughout the forecast period.

Asia-Pacific Veterinary Nutraceuticals Market

Asia-Pacific is projected to be the fastest-growing regional market for veterinary nutraceuticals through 2036. This growth is being driven by expanding animal healthcare infrastructure, rising expenditure on companion animal care, rapid development of commercial livestock production, and increasing adoption of advanced animal nutrition solutions across the region.

The region plays a key role in global animal production. According to the Food and Agriculture Organization (FAO), Asia accounts for more than 50% of global aquaculture production and is the world's largest producer of poultry, swine, and several major livestock species. This large production base creates substantial demand for probiotics, prebiotics, phytogenics, yeast derivatives, and immune-support nutraceuticals aimed at improving animal performance and disease resilience.

Asia-Pacific is also becoming a major center for companion animal growth. According to the Japan Pet Food Association, Japan's pet population exceeds the country's child population under the age of 15, highlighting the region's evolving demographic and pet ownership trends. Meanwhile, China has become one of the world's largest pet care markets, with increasing adoption of premium pet foods, functional treats, and veterinary wellness products.

Furthermore, Asia is home to some of the world's largest feed-producing nations. According to the Alltech Global Feed Survey, China alone produces more than 300 million tonnes of animal feed annually, while several Asia-Pacific countries rank among the world's top feed producers. This extensive feed manufacturing infrastructure provides a strong platform for the incorporation of nutraceutical ingredients across poultry, swine, ruminant, and aquaculture applications.

Supported by rising animal health awareness, expanding livestock production, growing companion animal populations, and increasing adoption of preventive healthcare solutions, Asia-Pacific is expected to remain the fastest-growing market for veterinary nutraceuticals throughout the forecast period.

Europe Veterinary Nutraceuticals Market

Europe is one of the most advanced and innovation-driven markets for veterinary nutraceuticals globally. This is mainly due to its highly developed veterinary healthcare infrastructure, strong animal welfare standards, and widespread adoption of preventive animal health practices. European consumers and livestock producers increasingly prioritize evidence-based nutritional interventions, driving demand for premium veterinary nutraceutical products across both companion animal and production animal sectors.

Europe maintains a substantial livestock production base that supports demand for functional feed additives and livestock nutraceuticals. According to the European Feed Manufacturers' Federation (FEFAC), the European Union manufactures approximately 147 million tonnes of compound feed annually, including significant volumes for poultry, swine, dairy cattle, and aquaculture. This large feed sector creates opportunities for probiotics, phytogenics, yeast derivatives, organic acids, and immune-support nutraceuticals aimed at improving animal performance and health.

The region also benefits from a highly developed veterinary workforce. According to the Federation of Veterinarians of Europe (FVE), Europe has more than 330,000 veterinarians, one of the largest veterinary professional communities globally. The strong presence of veterinary professionals supports greater awareness, recommendation, and adoption of nutraceutical products for joint health, gastrointestinal disorders, dermatological conditions, and preventive care.

Europe remains a global center for animal health innovation. The region hosts several major veterinary health and nutraceutical companies, including Virbac, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, and VetPlus, alongside numerous research institutes specializing in animal nutrition and microbiome science. Continued investment in clinical validation, precision nutrition, and functional feed technologies has strengthened Europe's position as a leading hub for veterinary nutraceutical development.

In addition, Europe is one of the world's largest dairy-producing regions. According to the European Commission, the European Union produces more than 145 million tonnes of raw milk annually, creating substantial demand for nutraceutical solutions that support dairy cattle health, fertility, immunity, and productivity. As producers seek to improve animal performance while maintaining high welfare standards, adoption of functional nutrition products is expected to continue increasing.

Supported by a large veterinary workforce, a strong feed manufacturing industry, extensive livestock production, and continuous innovation in animal nutrition, Europe is expected to remain a key high-value market for veterinary nutraceuticals throughout the forecast period.

Competitive Landscape

The global veterinary nutraceuticals market is moderately fragmented, with competition spanning animal health companies, veterinary nutraceutical specialists, pet nutrition manufacturers, and animal nutrition firms. The companies compete primarily on scientific validation, veterinary recommendations, product efficacy, ingredient quality, brand reputation, and distribution reach. As demand shifts toward preventive animal healthcare, companies are increasingly investing in clinically supported formulations targeting joint health, digestive health, immunity, cognition, and dermatological conditions.

Leading companies such as Zoetis, Elanco, Virbac, Boehringer Ingelheim, Dechra Pharmaceuticals, Nutramax Laboratories, and VetPlus leverage extensive veterinary relationships, established distribution networks, and strong research capabilities to strengthen their market positions. Meanwhile, nutrition-focused players including Hill's Pet Nutrition, Royal Canin, Purina, Alltech, Kemin Industries, and Phibro Animal Health continue expanding functional nutrition and wellness portfolios to capture growing demand for preventive health solutions.

Strategic partnerships, acquisitions, and product portfolio expansion continue to shape the competitive environment. For example, major animal health companies have expanded investments in companion animal wellness products, while livestock-focused companies are strengthening capabilities in probiotics, phytogenics, and antibiotic-alternative nutrition solutions. In addition, growing e-commerce adoption has enabled emerging brands to expand market reach through direct-to-consumer channels, increasing competition within the companion animal segment.

The market is expected to witness increasing consolidation over the coming years as larger animal health companies seek to strengthen preventive healthcare portfolios and capitalize on growing demand for science-backed veterinary nutraceuticals.

Key Players in the Veterinary Nutraceuticals Market

The key companies operating in the global market are: Nutramax Laboratories, Inc., Virbac S.A., Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Hill's Pet Nutrition, Inc. (Colgate-Palmolive Company), Mars, Incorporated (Royal Canin), Nestlé Purina PetCare Company, VetPlus Ltd, Phibro Animal Health Corporation, Kemin Industries, Inc., Alltech, Inc., and Other Players.